Infant Bacterial Therapeutics offentliggör prospekt i samband med listbytet till Nasdaq Stockholm
September 04, 2018 10:20 ET
|
Infant Bacterial Therapeutics AB
Den 30 augusti 2018 meddelade Infant Bacterial Therapeutics AB (publ) ("IBT" eller "Bolaget") att Nasdaq Stockholms bolagskommittée godkände ansökan om upptagande till handel av Bolagets aktier i...
Infant Bacterial Therapeutics publishes prospectus in connection with the list change to Nasdaq Stockholm
September 04, 2018 10:20 ET
|
Infant Bacterial Therapeutics AB
On August 30, 2018, Infant Bacterial Therapeutics AB (publ) (”IBT” or the ”Company”) announced that Nasdaq Stockholm’s Listing Committee had approved the admission of the Company’s shares of series B...